Currently out of the existing stock ratings of Mitchell Kapoor, 127 are a BUY (94.07%), 8 are a HOLD (5.93%).

Mitchell Kapoor

Work Performance Price Targets & Ratings Chart

Analyst Mitchell Kapoor, currently employed carries an average stock price target met ratio of 38.01% that have a potential upside of 27.08% achieved within 67 days. Previously, Mitchell Kapoor worked at HC WAINWRIGHT.

Mitchell Kapoor’s has documented 268 price targets and ratings displayed on 11 stocks. The coverage was on the Healthcare sector.

Most recent stock forecast was given on HALO, Halozyme Therapeutics at 25-Nov-2024.

Wall Street Analyst Mitchell Kapoor

Analyst best performing recommendations are on TIL (INSTIL BIO .).
The best stock recommendation documented was for LEGN (LEGEND BIOTECH CORP) at 4/18/2023. The price target of $66 was fulfilled within 3 days with a profit of $13.76 (26.34%) receiving and performance score of 87.8.

Average potential price target upside

IMGO Imago Biosciences IPSC Century Therapeutics LEGN Legend Biotech Corp LYEL Lyell Immunopharma RAIN Rain Therapeutics RANI Rani Therapeutics Holdings TYRA Tyra Biosciences HALO Halozyme Therapeutics RLYB Rallybio Corp RPHM Reneo Pharmaceuticals TIL Instil Bio .

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

$36

$-0.01 (-0.03%)

$36

2 years 6 days ago
(28-Nov-2022)

3/3 (100%)

$0.35 (0.98%)

267

Hold

$36

$-0.01 (-0.03%)

$35

2 years 12 days ago
(22-Nov-2022)

3/4 (75%)

$0.4 (1.12%)

145

Hold

$36

$-0.01 (-0.03%)

2 years 12 days ago
(22-Nov-2022)

1/1 (100%)

$0.4 (1.12%)

48

Hold

$36

$-0.01 (-0.03%)

$30

2 years 12 days ago
(22-Nov-2022)

2/2 (100%)

$0.4 (1.12%)

258

Hold

$36

$-0.01 (-0.03%)

$25

2 years 13 days ago
(21-Nov-2022)

2/2 (100%)

$0.41 (1.15%)

37

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is Mitchell Kapoor is most bullish on?

Potential upside of $83.09 has been obtained for TIL (INSTIL BIO .)

Which stock is Mitchell Kapoor is most reserved on?

Potential downside of -$0.1 has been obtained for LYEL (LYELL IMMUNOPHARMA)

What Year was the first public recommendation made by Mitchell Kapoor?

On 2022

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?